Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
First Published:
9/6/2007
1.
Phase II Study of Photodynamic Therapy Using HPPH in Patients With Advanced Obstructing Endobronchial Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
RPCI-I-98707
I98707, NCT00528775
Last Modified:
5/7/2007
 
First Published:
5/1/2007
2.
Phase I Pilot Study of Photodynamic Therapy Comprising HPPH in Patients Undergoing Surgery For Primary or Recurrent Squamous Cell Cancer of the Head and Neck
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
NCI
RPCI-I-74606
NCT00470496
First Published:
8/30/2007
3.
Phase I Study of Photodynamic Therapy Using HPPH in Patients With In Situ or Microinvasive Bronchogenic Non-Small Cell Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
NCI
RPCI-I-05903
I 05903, NCT00526461
First Published:
4/29/2008
4.
Phase I Study of Photodynamic Therapy Comprising HPPH in Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Squamous Cell Carcinoma of the Oral Cavity
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
NCI
RPCI-I-109307
I 109307, NCT00670397
Last Modified:
5/27/2008
 
First Published:
5/7/2008
5.
Phase I Study of Photodynamic Therapy Using HPPH in Patients With Dysplasia, Squamous Cell Carcinoma in Situ, or T1 Squamous Cell Carcinoma of the Larynx
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
NCI
RPCI-I-119207
I 119207, NCT00675233
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute